Skip survey header

Global Covid-19 Medicinal Plant Project

Global Covid-19 Medicinal Plant Project

QUESTIONNAIRE
Thank you for participating in this project to explore medicinal plants used in response to  Covid-19, initiated by Asili Research Alliance.  Asili Research Alliance is a non-profit organization researching medicinal plants in East Africa. Data from this survey will be compiled into an open-access, academic research publication to demonstrate the diversity of traditional medicines being used to manage Covid-19. Please let anyone who contributes information to this questionnaire know that it will be shared publicly.

Authorship
All contributions will be acknowledged in aggregate. Those contributing full information for their region of expertise will be listed as a co-author for their collaboration, unless they notify us otherwise.  Please send all inquiries to project@asiliresearchalliance.org. We appreciate your responses and greatly look forward to the collaboration.

Bhaswati Bhattacharya, MPH, MD, PhD, Advisor, Asili Research Alliance
Steven King, PhD, Advisor, Asili Research Alliance
Terra Reneau, Director of Operations, Asili Research Alliance
Jennifer Woltz, MS, Co-founder and Executive Director, Asili Research Alliance

 
 Please answer the following questions in as much detail as possible and in paragraph form. There is no word limit. For each question please specify if the plant-based formula is used to prevent Covid-19 or treat Covid-19, or both.  Questions that are not relevant to your region or area of expertise may be skipped.  Please complete this questionnaire by February 1st, 2021.  
PERSONAL INFORMATION
This question requires a valid date format of MM/DD/YYYY.
Ethical Considerations
During the project, the International Society of Ethnobiology Code of Ethics (http://ethnobiology.net/code-of-ethics/) will be followed. This includes obtaining consent, full disclosure of intent, required permissions being granted, respect for cultural norms and beliefs. Please refer to the website above for complete information. 

Statement of Benefit Sharing
Data from this project will be compiled into an open-access, academic research publication to demonstrate the diversity of traditional medicines being used to treat Covid-19.  No organization or individual may utilize this information to create products for sale without first obtaining permission from the source of the information. Contact information can be requested through Asili Research Alliance.  The organization or individual must also agree to provide benefit sharing to the source of the knowledge, to be determined by an agreement between the parties involved and following the international standards for permission and benefit sharing as defined in the Convention on Biological Diversity (CBD) and the Nagoya Protocol. The intent of this information gathering and publication is to facilitate the exchange of information among people and communities, which may help with managing the impact of COVID-19. Any organization, person or community is solely responsible for the potential positive or negative outcomes that may occur when and if any of these treatments with these traditional medicines may be utilized.